Oak Associates’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-3,350
Closed -$423K – 136
2024
Q4
$423K Sell
3,350
-350
-9% -$52K 0.03% 123
2024
Q3
$615K Hold
3,700
– – 0.04% 113
2024
Q2
$492K Sell
3,700
-1,123
-23% -$135K 0.03% 122
2024
Q1
$507K Hold
4,823
– – 0.04% 123
2023
Q4
$364K Hold
4,823
– – 0.03% 127
2023
Q3
$318K Buy
4,823
+1,623
+51% +$121K 0.03% 128
2023
Q2
$260K Sell
3,200
-1,021
-24% -$72.7K 0.02% 128
2023
Q1
$251K Hold
4,221
– – 0.02% 131
2022
Q4
$206K Buy
+4,221
New +$195K 0.02% 141

Other funds holding THC

Oak Associates's THC Position: Q1 2025 in Review

Oak Associates sold out of Tenet Healthcare (THC) in Q1 2025, closing a stake of 3,350 shares — an estimated $423K sold.

Oak Associates first reported a position in THC in Q4 2022 and held it in 9 quarters. The position peaked at $615K in Q3 2024. 567 funds tracked by Wall St. Rank hold THC as of Q1 2025.

  • Oak Associates reported no remaining Tenet Healthcare position as of Q1 2025 after selling out during the quarter.
  • Oak Associates sold 3,350 Tenet Healthcare shares in Q1 2025, an estimated $423K.
  • Oak Associates first reported a position in Tenet Healthcare in Q4 2022 and held it in 9 quarters.
  • Oak Associates's Tenet Healthcare position peaked at $615K in Q3 2024.
  • 567 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2025.

Based on Oak Associates's 13F filing for Q1 2025, filed 14 May 2025.